Penicillamine, enantiomers

Kovacs-Hadady and Kiss [27] studied the chromatographic characteristics of thia-zolidinecarboxylic acid derivatives, formed by reaction of (i>) and (L)-penicillamine with various substituted benzaldehydes and heterocyclic aldehydes in order to evaluate the aldehydes as derivatizing agents for separation of the penicillamine enantiomers. The TLC method of Martens et al. [28] was used. Transformation to thiazolidine carboxylic acids with benzaldehyde and substituted benzaldehydes was not complete, so formaldehyde is still the preferred reagent for separation of the enantiomers. 

Merino-Merino et al. [32] used the OPA reagent (o-phthaldehyde condensed with 2-mercaptoethanol) to separate penicillamine enantiomers after their derivatization. Racemic and (/q-penicillamine were dissolved in aqueous 0.5 M NaOH, and treated with the derivatizing solution (methanolic o-phthaldehyde and 2-mercaptoethanol in 0.4 M potassium borate buffer solution of pH 10). The reaction mixture was set aside for 2 min at room temperture, whereupon a portion of solution was analyzed by HPLC. The method used a Cyclobond column (25 cm x 4.6 mm) maintained at 5 °C, a mobile phase of ethanol/1% triethylammonium acetate (1 1 pH 4.5) eluted at... 

The description of diorganotin complexes with penicillamine enantiomers and 3-thiopropanoic add in the solid state was undertaken. The 3-thiopropanoic acid complexes derivatives contain both trigonal bipyramidal and tetrahedral structures about the tin. These structures are maintained initially after solution. Again, cyclic formation with chelation occurring with the carbonyl oxygen of the carboxylic group occurs [66]. 

Kovacs-Hadady, K. and Kiss, I.T., Attempts for the chromatographic separation of D- and L-penicillamine enantiomers, Chromatographia, 24, 677,1987. 

The amino acids L-leucine, T-phenylalanine, L-tyrosine, and L-tryptophan all taste bitter, whereas their D-enantiomers taste sweet (5) (see Amino ACIDS). D-Penicillamine [52-67-5] a chelating agent used to remove heavy metals from the body, is a relatively nontoxic dmg effective in the treatment of rheumatoid arthritis, but T.-penicillamine [1113-41 -3] produces optic atrophy and subsequent blindness (6). T.-Penicillamine is roughly eight times more mutagenic than its enantiomer. Such enantioselective mutagenicity is likely due to differences in renal metaboHsm (7). (R)-ThaHdomide (3) is a sedative—hypnotic (3)-thaHdomide (4) is a teratogen (8). 

One enantiomer of penicillamine (D-) exhibits antiarthritic properties but foe other is highly toxic (Figure 8.3). The teratogenic effects of thalidomide were induced by one enantiomer, foe other exhibited foe beneficial effects against morning sickness. 

The enantiomers of this drug differ in their efficacy and activity, with (D)-penicilla-mine being the enantiomer required for pharmaceutical preparations. The (l)-enantiomer is toxic, and its absorption by the human body is more than the (D)-enantiomer. While both enantiomers of penicillamine are desulfhydrated by (r.)-cysteine desulfhydrase, only the (l)-isomer inhibits the action of this enzyme [2], The reported optical rotation values for (D)-penicillamine are ... 

Gotti et al. [42] reported an analytical study of penicillamine in pharmaceuticals by capillary zone electrophoresis. Dispersions of the drug (0.4 mg/mL for the determination of (/q-penicillaminc in water containing 0.03% of the internal standard, S -met hy I - r-cystei ne, were injected at 5 kPa for 10 seconds into the capillary (48.5 cm x 50 pm i.d., 40 cm to detector). Electrophoresis was carried out at 15 °C and 30 kV, with a pH 2.5 buffer of 50 mM potassium phosphate and detection at 200 rnn. Calibration graphs were linear for 0.2-0.6 pg/mL (detection limit = 90 pM). For a more sensitive determination of penicillamine, or for the separation of its enantiomers, a derivative was prepared. Solutions (0.5 mL, final concentration 20 pg/mL) in 10 mM phosphate buffer (pH 8) were mixed with 1 mL of methanolic 0.015% 1,1 -[ethylidenebis-(sulfonyl)]bis-benzene and, after 2 min, with 0.5 mL of pH 2.5 phosphate buffer. An internal standard (0.03% tryptophan, 0.15 mL) was added and aliquots were injected. With the same pH 2.5 buffer and detection at 220 nm, calibration graphs were linear for 9.3-37.2 pg/mL, with a detection limit of 2.5 pM. For the determination of small amounts of (L)-penicillamine impurity, the final analyte concentration was 75 pg/mL, the pH 2.5 buffer contained 5 mM beta-cyclodextrin and 30 mM (+)-camphor-10-sulfonic acid, with a voltage of 20 kV, and detection at 220 nm. Calibration graphs were linear for 0.5-2% of the toxic (L)-enantiomer, with a detection limit of 0.3%. 

The (n)-enantiomer of penicillamine is used clinically in man either as the hydrochloride or as the free amino acid [1], although the (L)-enantiomer also forms chelation complexes. Penicillamine is an effective chelator of copper, mercury, zinc, and lead, and other heavy metals to form stable, soluble complexes that are readily excreted in the urine [2,3]. 

Abou-Basha and Aboul-Enein [22] presented an isocratic and simple HPLC method for the direct resolution of the clenbuterol enantiomers. The method involved the use of a urea-type CSP made of hS )-indoline-2-carboxylic acid and (R)-1 -(naphthyl) ethylamine known as the Chirex 3022 column. The separation factor (a) obtained was 1.27 and the resolution factor (Rs) was 4.2 when using a mobile phase composed of hexane-1,2-dichloroethane-ethanol (80 10 10, v/v/v). The (+)-enantiomer eluted first with a capacity factor (k) of 2.67 followed by a (—)-enantiomer with a k of 3.38. Biesel et al. [23] resolved 1-benzylcyclohexane-1,2-diamine hydrochloride on a Chirex D-penicillamine column. Gasparrini et al. [24] synthesized a series of the chiral selectors based on /ra s -1,2 - d i a m i n o eye I o hexane. The developed CSPs were used for the chiral resolution of arylacetic acids, alcohols, sulfoxides, selenoxides, phosphinates, tertiary phosphine oxides, and benzodiazepines. In another study, the same authors [25] described the chiral resolution of /i-aminocstcrs enantiomers on synthetic CSPs based on a re-acidic derivatives of trans- 1,2-diaminocyclohexane... 

Cellulose was the first sorbent for which the resolution of racemic amino acids was demonstrated [23]. From this beginning, derivatives such as microcrystalline triacetylcellulose and /3-cyclodextrin bonded to silica were developed. The most popular sorbent for the control of optical purity is a reversed-phase silica gel impregnated with a chiral selector (a proline derivative) and copper (II) ions. Separations are possible if the analytes of interest form chelate complexes with the copper ions such as D,L-Dopa and D.L-penicillamine [24], Silica gel has also been impregnated with (-) brucine for resolving enantiomeric mixtures of amino acids [25] and a number of amino alcohol adrenergic blockers were resolved with another chiral selector [26]. A worthwhile review on enantiomer separations by TLC has been published [27],... 

Copper chelates of amino acid enantiomers such as proline or phenylalanine have been used to resolve enantiomers of amino acids and structurally related compounds [241,245]. Other metals such as zinc and cadmium have also been used. Metal chelates have been used to resolve a-amino-a-hydroxy carboxy acids and a-methyl-a-amino acid enantiomers [246]. One example of pharmaceutical interest is the resolution of D-penicillamine from the L-antipod [247] and resolution of L,D-thyroxine [248]. 

The potent anti-arthritic agent penicillamine (21) and the anti-nausea agent thalidomide (22) are drugs that have one stereogenic centre. For these compounds, one enantiomer [(S)-21 and (J )-22, respectively] is beneficial and the other is highly toxic (21) or induces severe pre-natal deformities (22). Draw stereo diagrams of (S)-21 and (/ )-22. 

Penicillamine The (5)-enantiomer has antiarthritic activity the (/J)-form is extremely toxic... 

It should be noted, however, that despite the general preference for the marketing of synthetic chiral therapeutic agents in racemic form, a few synthetic chiral drugs were introduced in a unichiral form. Such exceptions included the above-mentioned levodopa and also n-penicillamine 31 [78], (-)-timolol 32 [87], methyl-dopa 33 [88], etc, and it is clear that in most such cases the choice of developing a unichiral form was dictated by overt serious toxicity present predominantly in the ofher enantiomer. 

Using chiral thiols for derivative formation, isoindoles are formed from amino acids and amino alcohols. BOC-L-cysteine, N-acetyl-L-cysteine, Af-acetyl-D-penicillamine [340] and l-thio-jS-D-glucose [341] have been shown to be suitable reagents which allow the separation of most amino acid enantiomers using reversed phase column chromatography. Thus, OPA/N-acetyl-L-cysteine has been used among others for the separation of enantiomers of aspartate [342], baclofen [343], norepinephrine, dopa [344] and lombricine [345]. 

---